Aimei Health Technology Co., Ltd
AFJK
$33.80
$0.792.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -37.66% | -34.90% | -86.54% | 169.14% | 928.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.66% | -34.90% | -86.54% | 169.14% | 928.13% |
| Operating Income | 37.66% | 34.90% | 86.54% | -169.14% | -928.13% |
| Income Before Tax | -77.91% | -52.66% | -30.22% | -75.55% | 70.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -77.91% | -52.66% | -30.22% | -75.55% | 70.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.91% | -52.66% | -30.22% | -75.55% | 70.35% |
| EBIT | 37.66% | 34.90% | 86.54% | -169.14% | -928.13% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -61.59% | -30.22% | 2.81% | -69.65% | -2.19% |
| Normalized Basic EPS | -61.69% | -30.29% | 2.84% | -69.79% | -1.91% |
| EPS Diluted | -61.59% | -30.22% | 2.81% | -69.65% | -2.19% |
| Normalized Diluted EPS | -61.69% | -30.29% | 2.84% | -69.79% | -1.91% |
| Average Basic Shares Outstanding | -42.62% | -32.18% | -32.18% | -19.31% | 74.08% |
| Average Diluted Shares Outstanding | -42.62% | -32.18% | -32.18% | -19.31% | 74.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |